Back
Sarepta Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
110.51
Seasonality Move:
16.38%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Sarepta Therapeutics Stock Forecast
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.7% based on the past 27 years of stock performance.
- Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
-
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $110.86. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.7% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
- Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
78.67
Prediction Charts
Market Cap:
10.59B
Price in USD:
110.86
Volume:
1.13M
Beta:
1.06
Technical Analysis
SMA50:
122.58
SMA100:
132.20
SMA200:
130.17
52-Wk Change:
33.47%
Stock Predictions
-
Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company. -
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 110.86 USD today. -
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 125.91 | 123.29 | 126.51 | 122.68 |
| Nov-4 | 123.30 | 123.07 | 124.03 | 121.01 |
| Nov-5 | 123.00 | 125.01 | 125.25 | 121.18 |
| Nov-6 | 126.50 | 127.97 | 128.32 | 122.45 |
| Nov-7 | 132.40 | 120.42 | 133.00 | 117.52 |
| Nov-8 | 120.50 | 121.61 | 121.96 | 116.32 |
| Nov-11 | 121.88 | 117.79 | 122.63 | 117.53 |
| Nov-12 | 118.00 | 114.29 | 118.73 | 114.12 |
| Nov-13 | 113.63 | 112.48 | 116.30 | 111.53 |
| Nov-14 | 112.58 | 109.11 | 112.58 | 109.01 |
| Nov-15 | 108.54 | 104.54 | 108.70 | 102.57 |
| Nov-18 | 102.88 | 104.67 | 105.98 | 102.16 |
| Nov-19 | 104.38 | 106.62 | 106.99 | 103.63 |
| Nov-20 | 110.46 | 110.86 | 111.38 | 108.72 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.